UNIVERSITY OF UTAH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 20881
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14029
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12989
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 100145
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9773
 
 
 
C07K PEPTIDES 8357
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 7933
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 65382
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 6141
 
 
 
C07D HETEROCYCLIC COMPOUNDS 40122

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,874 MULTI-SEQUENCE CAPTURE SYSTEMJul 14, 17Mar 01, 18[C12Q]
2018/0051,980 INTERFEROMETRY SYSTEM AND ASSOCIATED METHODSDec 21, 15Feb 22, 18[G01B]
2018/0037,810 ENCAPSULATED POROUS PROPPANTJun 02, 17Feb 08, 18[E21B, C09K]
2018/0030,429 Polypeptide Assemblies and Methods for the Production ThereofFeb 29, 16Feb 01, 18[C12N]
2018/0031,467 TEMPERATURE PROFILE FOR ROCK SAMPLE COMPOSITION ANALYSISJul 28, 17Feb 01, 18[C10B, G06F, G01N]
2018/0018,858 SKIN STRETCH FEEDBACK DEVICES, SYSTEMS, AND METHODSAug 11, 17Jan 18, 18[G06F, G08B]
2018/0009,851 COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE III SECRETION SYSTEMMar 15, 17Jan 11, 18[C12N, C12P, C07K]
2017/0368,196 BI-FUNCTIONAL ALLOSTERIC PROTEIN-DRUG MOLECULES FOR TARGETED THERAPYDec 11, 15Dec 28, 17[A61K]
2017/0368,334 SPINAL CORD STIMULATION SYSTEMAug 10, 17Dec 28, 17[A61N, A61B]
2017/0364,666 K-MER BASED STRAIN TYPINGJun 09, 17Dec 21, 17[G06F]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920333 Method of making induced pluripotent stem cellsDec 30, 15Mar 20, 18[C12N]
9913831 Methods and compositions for treating nephrogenic diabetes insipidusJun 16, 16Mar 13, 18[A61K]
9913926 Adhesive complex coacervates and method of making and using thereofSep 14, 12Mar 13, 18[A61L, C09J, C08F, C09D, A61F, C08L]
9913927 In situ solidifying complex coacervates and methods of making and using thereofJul 14, 15Mar 13, 18[A61L, C09D, A61K]
9907791 Ron inhibitors for use in preventing and treating bone lossMar 13, 15Mar 06, 18[A61K]
9907861 High molecular weight arginine-grafted bioreducible polymersJan 18, 13Mar 06, 18[C12N, A61K]
9901624 Methods and compositions for treating nephrogenic diabetes insipidusJun 16, 14Feb 27, 18[A61K]
9896384 Methods of sintering dense zeta-phase tantalum carbideJun 17, 15Feb 20, 18[C04B]
9889235 Implantable devices for bone or joint defectsFeb 05, 14Feb 13, 18[B29K, A61L, B29L, B29C, B05D, A61K]
9885085 Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditionsJun 28, 07Feb 06, 18[C12Q, G06F, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0323,080 DISEASE THERAPY GAME TECHNOLOGYABANJul 25, 17Nov 09, 17[G06F, A63F]
2017/0295,327 MULTI-SPECTRAL IMAGING WITH DIFFRACTIVE OPTICSABANJun 23, 17Oct 12, 17[H04N, G02B, G01J]
2017/0290,915 METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMORABANJun 27, 17Oct 12, 17[A61N, A61K]
2017/0228,616 SYSTEMS AND METHODS FOR IMAGE CLASSIFICATIONABANFeb 05, 16Aug 10, 17[G06K]
2017/0218,363 MORPHOLINO-MEDIATED INCREASE IN SOLUBLE FLT-1 EXPRESSION RESULTS IN DECREASED OCULAR AND TUMOR NEOVASCULARIZATIONABANNov 29, 16Aug 03, 17[C12N]
2017/0065,602 COMPOUNDS WITH TRPV4 ACTIVITY, COMPOSITIONS AND ASSOCIATED METHODS THEREOFABANSep 30, 16Mar 09, 17[C07D, A61K]
2017/0058,047 METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAMEABANApr 06, 16Mar 02, 17[C12Q, G01N, C07K]
2017/0051,075 METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAMEABANApr 06, 16Feb 23, 17[C12N, C12Q, A61K, G01N, C07K]
2016/0355,869 BIOSENSORS INCLUDING METALLIC NANOCAVITIESABANJan 12, 15Dec 08, 16[B01L, C12Q, G01N]
2016/0352,548 BLIND PHASE-SHIFT KEYING (PSK) AND QUADRATURE AMPLITUDE MODULATION (QAM) IDENTIFICATIONABANAug 09, 16Dec 01, 16[H04L, H04B]
2016/0258,022 Methods for Assessing Risk for Cardiac Dysrythmia in a Human SubjectABANMar 08, 16Sep 08, 16[C12Q]
2016/0208,327 SYSTEMS AND METHODS FOR DETERMINING IMPACT OF AGE RELATED CHANGES IN SPERM EPIGENOME ON OFFSPRING PHENOTYPEABANAug 21, 14Jul 21, 16[C12Q]
2016/0193,041 VISION CORRECTION SYSTEMABANMar 15, 16Jul 07, 16[A61F]
2016/0193,364 COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITYABANMar 23, 16Jul 07, 16[C12Q, A61K]
2016/0193,479 Brachytherapy Seed with Fast Dissolving Matrix for Optimal Delivery of Radionuclides to Cancer TissueABANMar 14, 16Jul 07, 16[A61N, B29C, B29B, A61K]
2016/0151,318 USE OF NITRATED LIPIDS FOR TREATMENT OF LIPID DISORDERS AND OBESITY, AND LIPID- AND OBESITY-RELATED CONDITIONSABANOct 23, 15Jun 02, 16[A61K]
2016/0129,111 METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMORABANJan 15, 16May 12, 16[A61N, A61K]
2016/0109,431 Development Of Natural Killer Cells And Functional Natural Killer Cell LinesABANAug 24, 15Apr 21, 16[G01N]
2016/0083,522 Arginine-Grafted Bioreducible Polymer Systems and Use in Treatment of Cardiac ConditionsABANMay 14, 14Mar 24, 16[C08G, A61K]
2016/0059,077 EXERCISE THERAPY AND REHABILITATION SYSTEM AND METHODABANAug 27, 15Mar 03, 16[A63B]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.